Clinical evidence dossier
mHealth diabetes support intervention
HbA1c
Evidence signal
Authoritative evidence signal
strong
This is an authoritative evidence signal supplied by Clinical Reference. It is not a formal clinical grade, treatment recommendation, or pooled effect estimate.
Evidence snapshot
- Authoritative support records
- 3
- Supporting studies available for review
- 3
- Randomized trials
- 3
- Reported effects
- 4
Clinical conclusion
mHealth diabetes support intervention has a small positive evidence signal for HbA1c, but the clinical interpretation is limited.
The conclusion and evidence-signal classification are distinct authoritative fields and are reproduced as published.
Observed effects
Observed study estimates; not a pooled treatment effect.
Change from baseline
Absolute change
-1 to -1 %
Between-group effect
Absolute change
7 to 7 %
Change from baseline
Mean difference
0 to 0 %
Change from baseline
Mean difference
-0.79 to -0.79 percentage points
Evidence composition
- Non-randomized studies
- 0
- Other designs
- 0
- Unresolved designs
- 0
- Magnitude-eligible effects
- 4
Consistency
Authoritative consistency classification
mixed
- Positive
- 1
- No effect
- 1
- Mixed
- 1
- Negative
- 0
Population and applicability
Structured population data were available for 3 of 3 supporting studies. Diabetes type was heterogeneous: 2 studies with type 2 diabetes, 1 studies with type 1 diabetes. Age groups were heterogeneous: 2 studies with adult participants, 1 studies with youth participants.
This population information refers to the materialized supporting studies available for review. Omitted support records remain part of the authoritative support accounting and are available through the audit experience.
View reported population descriptions
These descriptions are reported across the supporting studies; they are not a single synthesized population.
- Adults with type 2 diabetes.
- Patients receiving primary care for diabetes management.
- Families with school-age children diagnosed with Type 1 Diabetes
- Parents experiencing diabetes distress
- Adults aged 18 and older with type 2 diabetes.
- Individuals seeking mobile health support for diabetes management.
Limitations
- Upstream consistency scoring indicates mixed findings across the evidence.
- Evidence uses heterogeneous comparison contexts: baseline_within_group, usual_care.
Supporting evidence
Inspect the authoritative studies and omitted support records for this dossier.